Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: August 2013

Chapter 12 - Apathy

from Section 3 - Specific neuropsychiatric disorders

Related content

Powered by UNSILO

References

1. MarinRS.Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991; 3: 243–54.
2. StussDT, van ReekumR, MurphyKJ.Differentiation of states and causes of apathy. In BorodJ, ed., The Neuropsychology of Emotion. New York, NY: Oxford University Press; 2000. pp. 340–63.
3. LevyR, DuboisB.Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916–28.
4. RobertP, OnyikeCU, LeentjensAF, et al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 2009; 24: 98–104.
5. MulinE, LeoneE, DujardinK, et al. Diagnostic criteria for apathy in clinical practice. Int J Geriatr Psychiatry 2011; 26: 158–65.
6. DrijgersRL, DujardinK, ReijndersJS, DefebvreL, LeentjensAF.Validation of diagnostic criteria for apathy in Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 656–60.
7. AarslandD, MarshL, SchragA.Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009; 24: 2175–86.
8. PedersenKF, AlvesG, BrønnickK, et al. Apathy in drug-naive patients with incident Parkinson's disease: the Norwegian ParkWest study. J Neurol 2010; 257: 217–23.
9. PluckGC, BrownRG.Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 636–42.
10. CzerneckiV, PillonB, HouetoJL, et al. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002; 40: 2257–67.
11. DujardinK, SockeelP, DevosD, et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007; 22: 778–84.
12. DujardinK, SockeelP, DelliauxM, DesteeA, DefebvreL.Apathy may herald cognitive decline and dementia in Parkinson's disease. Mov Disord 2009; 24: 2391–7.
13. RobertPH, BerrC, VolteauM, et al. Apathy in patients with mild cognitive impairment and the risk of developing dementia of Alzheimer's disease: a one-year follow-up study. Clin Neurol Neurosurg 2006; 108: 733–6.
14. PedersenKF, AlvesG, AarslandD, LarsenJP.Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 2009; 80: 1279–82.
15. ReijndersJS, EhrtU, WeberWE, AarslandD, LeentjensAF.A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008; 23: 183–9.
16. Kirsch-DarrowL, FernandezHH, MarsiskeM, OkunMS, BowersD.Dissociating apathy and depression in Parkinson disease. Neurology 2006; 67: 33–8.
17. SockeelP, DujardinK, DevosD, et al. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 579–84.
18. StarksteinSE, MaybergHS, PreziosiTJ, et al. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4: 134–9.
19. LevyML, CummingsJL, FairbanksLA, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998; 10: 314–19.
20. RoyallDR.Some “depressive” symptoms may not imply depression. J Am Geriatr Soc 1997; 45: 891–2.
21. MarshL, McDonaldWM, CummingsJ, RavinaB.Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group. Mov Disord 2006; 21: 148–58.
22. Kleiner-FismanG, HerzogJ, FismanDN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21 (Suppl 14): S290–304.
23. MoroE, LozanoAM, PollakP, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010; 25: 578–86.
24. VoonV, KubuC, KrackP, HouetoJL, TrösterAI.Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21 (Suppl 14): S305–27.
25. Saint-CyrJA, TrepanierLL, KumarR, LozanoAM, LangAE.Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123: 2091–108.
26. FunkiewiezA, ArdouinC, CaputoE, et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 834–9.
27. CzerneckiV, PillonB, HouetoJL, et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?J Neurol Neurosurg Psychiatry 2005; 76: 775–9.
28. FunkiewiezA, ArdouinC, CoolsR, et al. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease. Mov Disord 2006; 21: 1656–62.
29. DrapierD, DrapierS, SauleauP, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?J Neurol 2006; 253: 1083–91.
30. CastelliL, PerozzoP, ZibettiM, et al. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol 2006; 55: 136–44.
31. CastelliL, LanotteM, ZibettiM, et al. Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study. J Neurol 2007; 254: 1238–43.
32. DrapierD, PeronJ, LerayE, et al. Emotion recognition impairment and apathy after subthalamic nucleus stimulation in Parkinson's disease have separate neural substrates. Neuropsychologia 2008; 46: 2796–801.
33. Le JeuneF, DrapierD, BourguignonA, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009; 73: 1746–51.
34. PoratO, CohenOS, SchwartzR, Hassin-BaerS.Association of preoperative symptom profile with psychiatric symptoms following subthalamic nucleus stimulation in patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci 2009; 21: 398–405.
35. ThoboisS, ArdouinC, LhomméeE, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010; 133: 1111–27.
36. Kirsch-DarrowL, ZahodneLB, MarsiskeM, et al. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 182–8.
37. CzerneckiV, SchüpbachM, YaiciS, et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 2008; 23: 964–9.
38. TemelY, Visser-VandewalleV, AendekerkB, et al. Acute and separate modulation of motor and cognitive performance in parkinsonian rats by bilateral stimulation of the subthalamic nucleus. Exp Neurol 2005; 193: 43–52.
39. CummingsJL.Frontal-subcortical circuits and human behavior. Arch Neurol 1993; 50: 873–80.
40. PessiglioneM, SchmidtL, DraganskiB, et al. How the brain translates money into force: a neuroimaging study of subliminal motivation. Science 2007; 316: 904–6.
41. MignecoO, BenoitM, KoulibalyPM, et al. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer's disease and nondemented patients. Neuroimage 2001; 13: 896–902.
42. SarazinM, MichonA, PillonB, et al. Metabolic correlates of behavioral and affective disturbances in frontal lobe pathologies. J Neurol 2003; 250: 827–33.
43. ReijndersJS, ScholtissenB, WeberWE, et al. Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry. Mov Disord 2010; 25: 2318–25.
44. RemyP, DoderM, LeesA, TurjanskiN, BrooksD.Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128: 1314–22.
45. PedersenKF, LarsenJP, AlvesG, AarslandD.Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord 2009; 15: 295–9.
46. ChatterjeeA, FahnS.Methylphenidate treats apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002; 14: 461–2.
47. WeintraubD, MavandadiS, MamikonyanE, et al. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 2010; 75: 448–55.
48. van ReekumR, StussDT, OstranderL.Apathy: why care?J Neuropsychiatry Clin Neurosci 2005; 17: 7–19.
49. TeriL, LogsdonRG, UomotoJ, McCurrySM.Behavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci Soc Sci 1997; 52: P159–66.
50. LeiknesI, TysnesOB, AarslandD, LarsenJP.Caregiver distress associated with neuropsychiatric problems in patients with early Parkinson's disease: the Norwegian ParkWest study. Acta Neurol Scand 2010; 122: 418–24.